Lantheus Holdings, Inc.
LNTH- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001521036
No open-market purchases or sales by Lantheus Holdings, Inc. insiders were filed in the last 90 days; 467 institutions reported holding it in 13F filings for Q2 2026, worth $8.34B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Lantheus Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Lantheus Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Marshall Robert J. Jr. | CFO and Treasurer | 122,071 | Sep 2, 2026 | 3 |
| Dinkelborg Ludger | See Remarks | 33,195 | Aug 19, 2026 | 2 |
| Brown Kimberly | Chief Accounting Officer | 13,263 | Aug 19, 2026 | 2 |
| Heino Mary Anne | Executive Chair and CEO | 321,897 | Jun 3, 2026 | 3 |
| Ber Gerard | Director | 27,118 | Jun 3, 2026 | 2 |
| Leno Sam R | Director | 67,246 | May 18, 2026 | 1 |
| Thrall James H | Director | 39,881 | May 18, 2026 | 1 |
| McHugh Julie | Director | 30,099 | May 18, 2026 | 1 |
| Eastland Julia Marie | Director | 8,019 | May 18, 2026 | 1 |
| Pruden Gary J | Director | 6,674 | May 18, 2026 | 1 |
| Baylor-Henry Minnie | Director | 14,018 | May 18, 2026 | 1 |
| Maeusli Heinz Christoph | Director | 30,014 | May 18, 2026 | 1 |
| Morrow Phuong Khanh | Director | 7,237 | May 18, 2026 | 1 |
| Niedzwiecki Daniel | See Remarks | 117,465 | Apr 21, 2026 | 3 |
| Morgan Amanda Michelle | Chief Commercial Officer | 64,153 | Mar 9, 2026 | 3 |
| Wehrly Mark C | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Patel Rajiv A | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Spokes Andrew J M | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Roberts Thomas G. Jr. | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Warren John R. | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Seybold William | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Saito Edric C. | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Short Daniel S. | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Farallon Partners L L C | 10% Owner, Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Fried Richard B | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Giauque Nicolas | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Linn Michael G | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Kim David T | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Dreyfuss Philip D | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Gehani Varun N | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Dapice Joshua J. | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Dunn Hannah E. | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Luo Patrick (Cheng) | Other: Member of a Group Owning 10% | 3,477,227Indirect | Aug 21, 2025 | 0 |
| Blanchfield Paul | President | 108,214 | Aug 15, 2025 | 0 |
| Markison Brian A | CEO | 232,420 | Mar 7, 2025 | 0 |
| Sabens Andrea | Chief Accounting Officer | 60,420 | Jul 17, 2024 | 0 |
| Humphrey Jeffrey | Chief Medical Officer | 9,076 | Jun 20, 2024 | 0 |
| Montagut Etienne | Chief Business Officer | 94,651 | Mar 7, 2024 | 0 |
| Provost Jean-Claude | Chief Medical Officer | 38,841Indirect | Mar 7, 2024 | 0 |
| Walker Carol | Senior Vice President, Quality | 64,899 | Apr 1, 2022 | 0 |
| Yao Ying Vivian | Chief Human Resources Officer | 30,319 | Mar 7, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2022 (view filing) | Apr 4 | 2 days | Montagut EtienneChief Business Officer | SSale | −12.7K | $57.38 | −$726.1K | −13.1%84.0K after | |
| Apr 1, 2022 (view filing) | Mar 30 | 2 days | Walker CarolSenior Vice President, Quality | SSale | −15.0K | $56.22 | −$843.3K | −18.8%64.9K after | |
| Mar 9, 2022 (view filing) | Mar 7-8 | 2 days | Niedzwiecki DanielSee Remarks | SSale | −1.76K | $52.08 | −$91.8K | −2.4%72.5K after | 2 lots |
| Mar 9, 2022 (view filing) | Mar 7 | 2 days | Blanchfield PaulChief Commercial Officer | SSale | −2.23K | $52.55 | −$117.1K | −2.8%76.4K after | |
| Mar 9, 2022 (view filing) | Mar 7 | 2 days | Marshall Robert J. Jr.CFO and Treasurer | SSale | −4.38K | $52.55 | −$230.2K | −2.9%145.9K after | |
| Mar 9, 2022 (view filing) | Mar 7 | 2 days | Walker CarolSenior Vice President, Quality | SSale | −1.59K | $52.55 | −$83.7K | −2.0%79.9K after | |
| Mar 9, 2022 (view filing) | Mar 7 | 2 days | Montagut EtienneChief Business Officer | SSale | −3.12K | $52.55 | −$163.7K | −3.1%96.6K after | |
| Mar 9, 2022 (view filing) | Mar 7-8 | 2 days | Sabens AndreaChief Accounting Officer | SSale | −1.62K | $52.09 | −$84.3K | −2.4%65.0K after | 2 lots |
| Mar 7, 2022 (view filing) | Mar 4 | 3 days | Marshall Robert J. Jr.CFO and Treasurer | SSale | −2.57K | $49.98 | −$128.4K | −1.7%150.3K after | |
| Mar 7, 2022 (view filing) | Mar 4 | 3 days | Blanchfield PaulChief Commercial Officer | SSale | −3.91K | $49.98 | −$195.6K | −4.7%78.7K after | |
| Mar 7, 2022 (view filing) | Mar 4 | 3 days | Montagut EtienneChief Business Officer | SSale | −1.64K | $49.98 | −$81.7K | −1.6%99.7K after | |
| Mar 7, 2022 (view filing) | Mar 4 | 3 days | Walker CarolSenior Vice President, Quality | SSale | −1.54K | $49.98 | −$76.8K | −1.8%81.5K after | |
| Mar 7, 2022 (view filing) | Mar 3-4 | 4 days | Heino Mary AnnePresident & CEO | SSale | −23.3K | $51.63 | −$1.21M | −3.2%707.4K after | 4 lots |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Sabens AndreaChief Accounting Officer | SSale | −2.41K | $48.04 | −$115.7K | −3.8%61.2K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Walker CarolSenior Vice President, Quality | SSale | −6.96K | $48.04 | −$334.2K | −8.4%75.6K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Marshall Robert J. Jr.CFO and Treasurer | SSale | −8.85K | $48.04 | −$425.2K | −6.5%126.9K after | |
| Mar 2, 2022 (view filing) | Feb 28 | 2 days | Heino Mary AnnePresident & CEO | SSale | −43.9K | $46.50 | −$2.04M | −6.3%655.6K after | 2 lots |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Montagut EtienneChief Business Officer | SSale | −5.99K | $48.04 | −$287.7K | −6.7%83.5K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Niedzwiecki DanielSee Remarks | SSale | −2.65K | $48.04 | −$127.1K | −4.3%58.5K after | |
| Feb 17, 2022 (view filing) | Feb 15 | 2 days | Sabens AndreaChief Accounting Officer | SSale | −1.24K | $28.64 | −$35.5K | −2.0%59.9K after | |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Sabens AndreaChief Accounting Officer | SSale | −1.24K | $26.93 | −$33.4K | −2.0%61.1K after | |
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Heino Mary AnnePresident & CEO | SSale | −14.1K | $28.61 | −$403.4K | −2.1%660.7K after | |
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Sabens AndreaChief Accounting Officer | SSale | −1.24K | $26.72 | −$33.2K | −2.0%62.3K after | |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Sabens AndreaChief Accounting Officer | SSale | −1.24K | $30.47 | −$37.8K | −1.9%63.6K after | |
| Nov 15, 2021 (view filing) | Nov 10 | 5 days | Heino Mary AnnePresident & CEO | SSale | −13.3K | $30.12 | −$401.6K | −1.9%674.8K after | |
| Oct 20, 2021 (view filing) | Oct 18-19 | 2 days | Marshall Robert J. Jr.CFO and Treasurer | SSale | −9.50K | $22.93 | −$217.8K | −7.0%127.0K after | 2 lots |
| Oct 20, 2021 (view filing) | Oct 18-19 | 2 days | Montagut EtienneChief Business Officer | SSale | −4.11K | $22.92 | −$94.3K | −4.7%83.6K after | 2 lots |
| Oct 19, 2021 (view filing) | Oct 15 | 4 days | Sabens AndreaChief Accounting Officer | SSale | −1.24K | $23.71 | −$29.4K | −1.9%64.8K after | |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Sabens AndreaChief Accounting Officer | SSale | −1.24K | $24.55 | −$30.5K | −1.8%66.1K after | |
| Sep 10, 2021 (view filing) | Sep 8 | 2 days | Montagut EtienneChief Business Officer | SSale | −457 | $26.06 | −$11.9K | −0.5%87.3K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Sabens AndreaChief Accounting Officer | SSale | −1.24K | $25.46 | −$31.6K | −1.8%67.3K after | |
| Aug 12, 2021 (view filing) | Aug 10 | 2 days | Heino Mary AnnePresident & CEO | SSale | −15.6K | $25.83 | −$402.4K | −2.2%688.2K after |